Loading

From Incubation to Acquisition: The Growth Journey of an Early-Stage Company

June 04, 2024
Breakout Session
Business Development and Investment
30ABC
Serotiny set out to revolutionize the way scientists design the genes encoding multi-domain proteins contributing to best-in-class cellular therapies. This panel discussion will dive into an early-stage company's entrepreneurial journey from incubation to strategic partnership and investment to acquisition.
Speakers
Melinda Richter
Global Head
Johnson & Johnson
Speakers
Colin Farlow
Co-Founder and CEO
Serotiny
Matt Lorenzi, PhD
Vice President
Johnson & Johnson
Leo MacDonald
Vice President
Johnson & Johnson Innovative Medicine
Eric Moessinger
Partner
+ND Capital

Sponsored by:

johnson and johnson
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS